|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.310 USD | -3.35% |
|
-2.12% | +28.33% |
| May. 13 | Protalix BioTherapeutics, Inc., Q1 2026 Earnings Call, May 13, 2026 | |
| May. 13 | Protalix BioTherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| Market Cap | 186M 163M 150M 139M 262M 17.88B 266M 1.79B 704M 8.75B 699M 684M 30.14B | P/E 2026 * |
11.8x | P/E 2027 * | 46.2x |
|---|---|---|---|---|---|
| Enterprise Value | 186M 163M 150M 139M 262M 17.88B 266M 1.79B 704M 8.75B 699M 684M 30.14B | EV / Sales 2026 * |
2.38x | EV / Sales 2027 * | 2.75x |
| Free-Float |
96.12% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Protalix BioTherapeutics, Inc.
| 1 day | -3.35% | ||
| 1 week | -2.12% | ||
| Current month | -0.86% | ||
| 1 month | +10.53% | ||
| 3 months | -2.12% | ||
| 6 months | +12.14% | ||
| Current year | +28.33% |
| 1 week | 2.3 |  | 2.48 |
| 1 month | 2 | | 2.48 |
| Current year | 1.72 | | 3.19 |
| 1 year | 1.38 | | 3.19 |
| 3 years | 0.82 | | 3.19 |
| 5 years | 0.7 | | 3.55 |
| 10 years | 0.7 | | 15.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
Dror Bashan
CEO | Chief Executive Officer | 59 | 2019-06-29 |
Gilad Mamlok
DFI | Director of Finance/CFO | 57 | 2025-08-23 |
Ori Kalid
CTO | Chief Tech/Sci/R&D Officer | - | 2024-05-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Amos Bar Shalev
BRD | Director/Board Member | 73 | 2008-06-30 |
Aharon Schwartz
BRD | Director/Board Member | 82 | 2014-10-31 |
Dror Bashan
BRD | Director/Board Member | 59 | 2019-06-29 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| Dec. 18 | Buy | Chief Executive Officer | 56,000 | 0.0696% | ||
| Nov. 17 | Sell | Director | 168 | 0.0002% | ||
| 25-09-02 | Free | Chairman | 22,500 | 0.0282% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.35% | -2.12% | +62.68% | +29.05% | 186M | |
| -2.48% | -6.72% | +44.19% | +156.43% | 1,028B | |
| -1.52% | -5.01% | +61.87% | +58.79% | 611B | |
| -1.30% | -3.88% | +27.81% | +79.97% | 432B | |
| +0.09% | -2.30% | +28.31% | +22.00% | 323B | |
| -0.42% | -3.18% | +26.90% | +43.55% | 277B | |
| +0.52% | -12.64% | +18.52% | +21.96% | 257B | |
| +0.51% | -0.57% | -25.81% | -40.06% | 217B | |
| -1.44% | -3.49% | +19.60% | +56.20% | 192B | |
| -1.04% | -4.63% | +16.01% | +68.47% | 161B | |
| Average | -0.48% | -4.93% | +28.01% | +49.64% | 349.85B | |
| Weighted average by Cap. | -0.08% | -5.52% | +33.55% | +76.97% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 78.3M 68.42M 63.25M 58.44M 110M 7.52B 112M 754M 296M 3.68B 294M 288M 12.68B | 67.56M 59.04M 54.58M 50.43M 94.96M 6.49B 96.68M 651M 255M 3.18B 254M 248M 10.94B |
| Net income | 15.72M 13.74M 12.7M 11.73M 22.1M 1.51B 22.5M 151M 59.43M 739M 59.06M 57.75M 2.55B | 4.07M 3.56M 3.29M 3.04M 5.73M 391M 5.83M 39.24M 15.4M 192M 15.3M 14.96M 660M |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-14 | $2.310 | -3.35% | 813,462 |
| 26-07-13 | $2.390 | -2.05% | 534,967 |
| 26-07-10 | $2.440 | +2.95% | 678,250 |
| 26-07-09 | $2.370 | -0.42% | 504,153 |
| 26-07-08 | $2.380 | +0.85% | 584,301 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PLX Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
